CEO of Dan­ish im­munother­a­py start­up hits the ex­it in the lat­est C-suite shake­up

Evax­ion Biotech, a Dan­ish start­up that us­es AI to de­vel­op per­son­al­ized im­muno-on­col­o­gy ther­a­pies, is shak­ing up its C-suite.

Lars Staal Weg­n­er has de­cid­ed to ex­it …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER